US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

'Secret Shoppers' Get ACA Plan Runaround No Photo Available

Dan McKay

Georgetown University researchers shopping incognito for Affordable Care Act insurance plans found misleading claims and even outright... (more story)

Courts Rule On GLP-1 Shortage Row, 340B In Colo. And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a Fifth Circuit ruling backing the removal of certain GLP-1 medications from the national drug sh... (more story)

3 Things To Know: Texas Judge Halts Abortion Drug Suit No Photo Available

Mark Payne

A Texas federal judge has paused a lawsuit challenging the U.S. Food and Drug Administration's approval of abortion medication mifepri... (more story)